Skip to main content
. Author manuscript; available in PMC: 2019 Oct 3.
Published in final edited form as: Cancer Genet Cytogenet. 1998 Jul 15;104(2):111–114. doi: 10.1016/s0165-4608(97)00452-4

Table 1.

Clinical and genetic data for cutaneous sporadic melanoma patients

Patient Age/sex Location Type Thicknessa Instabilityb

  1   73/M Shoulder SS 7.4 mm ND
  2   54/M Back SS 0.2 mm D5S107c
  3   50/M Metastasis UND ND
  4   40/M Metastasis UND ND
  5   39/F Metastasis UND ND
  6   92/M Scalp SS 1.3 mm D1S187c
  7   30/F Arm SS 3.4 mm ND
  8   44/M Shoulder LM 0.5 mm ND
  9   43/F Vulva SS 1.3 mm ND
10   55/M Back SS 1.5 mm D17S786c
11   34/F Leg SS 1.1 mm ND
12   71/M Metastasis UND D1S187c
13   44/F Breast SS 0.2 mm ND
14   52/M Back SS 0.8 mm D6S357c + D1S187c
15   63/M Back SS 0.8 mm ND
16   35/F Arm SS 0.7 mm ND
17   64/M Scalp SS 0.5 mm ND
18   76/M Unknown SS 0.9 mm ND
19   45/M Chest SS 0.9 mm D6S357d
20   81/M Back SS 1.2 mm ND

Abbreviations: ND, no instability detected; SS, superficial spreading; UND, type not determined; LM, lentigo maligna.

a

Thickness of metastatic specimens.

b

Patient’s samples show instability at the indicated sites.

c

Replication error at locus indicated.

d

Loss of heterozygosity.